Literature DB >> 23201260

P2X₃ and TRPV1 functionally interact and mediate sensitization of trigeminal sensory neurons.

J L Saloman1, M-K Chung1, J Y Ro2.   

Abstract

Musculoskeletal pain conditions, particularly those associated with temporomandibular disorders (TMD) affect a large percentage of the population. Identifying mechanisms underlying hyperalgesia could contribute to the development of new treatment strategies for the management of TMD and other muscle pain conditions. In this study, we provide evidence of functional interactions between two ligand-gated channels, P2X₃ and transient receptor potential V1 (TRPV1), in trigeminal sensory neurons, and propose that the interactions serve as an underlying mechanism for the development of mechanical hyperalgesia. Mechanical sensitivity of the masseter muscle was assessed in lightly anesthetized rats via an electronic anesthesiometer (Ro et al., 2009). Direct intramuscular injection of a selective P2X₃ agonist, alpha,beta-methylene adenosine triphosphate (αβmeATP), induced a dose- and time-dependent hyperalgesia. Mechanical sensitivity in the contralateral muscle was unaffected suggesting local P2X₃ mediate hyperalgesia. Anesthetizing the overlying skin had no effect on αβmeATP-induced hyperalgesia confirming the contribution of P2X₃ from the muscle. Importantly, the αβmeATP-induced hyperalgesia was prevented by pretreatment of the muscle with a TRPV1 antagonist, AMG9810. P2X₃ was co-expressed with TRPV1 in the masseter muscle afferents confirming the possibility for intracellular interactions. Additionally, in a subpopulation of P2Xv/TRPV1 positive neurons, capsaicin-induced Ca(2+) transients were significantly amplified following P2X₃ activation. Finally, activation of P2X₃ induced phosphorylation of serine, but not threonine, residues in TRPV1 in trigeminal ganglia cultures. Significant phosphorylation was observed at 15 min, the time point at which behavioral hyperalgesia was prominent. Previously, activation of either P2X₃ or TRPV1 had been independently implicated in the development of mechanical hyperalgesia. Our data propose P2X₃ and TRPV1 interact in a facilitatory manner, which could contribute to the peripheral sensitization known to underlie masseter hyperalgesia.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23201260      PMCID: PMC3600407          DOI: 10.1016/j.neuroscience.2012.11.015

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  77 in total

1.  Sensing muscle ischemia: coincident detection of acid and ATP via interplay of two ion channels.

Authors:  William T Birdsong; Leonardo Fierro; Frank G Williams; Valeria Spelta; Ligia A Naves; Michelle Knowles; Josephine Marsh-Haffner; John P Adelman; Wolfhard Almers; Robert P Elde; Edwin W McCleskey
Journal:  Neuron       Date:  2010-11-18       Impact factor: 17.173

2.  Characterization of dental nociceptive neurons.

Authors:  H Y Kim; G Chung; H J Jo; Y S Kim; Y C Bae; S J Jung; J-S Kim; S B Oh
Journal:  J Dent Res       Date:  2011-03-01       Impact factor: 6.116

3.  Activation of CaMKII and ERK1/2 contributes to the time-dependent potentiation of Ca2+ response elicited by repeated application of capsaicin in rat DRG neurons.

Authors:  Xiulin Zhang; Stephanie L Daugherty; William C de Groat
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-22       Impact factor: 3.619

4.  Contributions of peripheral and central opioid receptors to antinociception in rat muscle pain models.

Authors:  Eva Ma Sánchez; Ana Bagües; Ma Isabel Martín
Journal:  Pharmacol Biochem Behav       Date:  2010-07-15       Impact factor: 3.533

5.  Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus.

Authors:  Qin Liu; Zongxiang Tang; Lenka Surdenikova; Seungil Kim; Kush N Patel; Andrew Kim; Fei Ru; Yun Guan; Hao-Jui Weng; Yixun Geng; Bradley J Undem; Marian Kollarik; Zhou-Feng Chen; David J Anderson; Xinzhong Dong
Journal:  Cell       Date:  2009-12-10       Impact factor: 41.582

6.  A-kinase anchoring protein 150 controls protein kinase C-mediated phosphorylation and sensitization of TRPV1.

Authors:  Nathaniel A Jeske; Amol M Patwardhan; Nikita B Ruparel; Armen N Akopian; Mark S Shapiro; Michael A Henry
Journal:  Pain       Date:  2009-09-19       Impact factor: 6.961

7.  Activation of TRPV1 and TRPA1 leads to muscle nociception and mechanical hyperalgesia.

Authors:  Jin Y Ro; Jong-Seok Lee; Youping Zhang
Journal:  Pain       Date:  2009-05-22       Impact factor: 6.961

8.  The effects of sympathetic outflow on upregulation of vanilloid receptors TRPV(1) in primary afferent neurons evoked by intradermal capsaicin.

Authors:  Xijin Xu; Peng Wang; Xiaoju Zou; Dingge Li; Li Fang; Kerui Gong; Qing Lin
Journal:  Exp Neurol       Date:  2009-12-28       Impact factor: 5.330

9.  Eccentric muscle contraction and stretching evoke mechanical hyperalgesia and modulate CGRP and P2X(3) expression in a functionally relevant manner.

Authors:  Dean Dessem; Ranjinidevi Ambalavanar; Melena Evancho; Aicha Moutanni; Chandrasekhar Yallampalli; Guang Bai
Journal:  Pain       Date:  2010-03-05       Impact factor: 7.926

10.  Activation of cytosolic phospholipase A2 in dorsal root ganglion neurons by Ca2+/calmodulin-dependent protein kinase II after peripheral nerve injury.

Authors:  Shigeo Hasegawa; Yuta Kohro; Makoto Tsuda; Kazuhide Inoue
Journal:  Mol Pain       Date:  2009-05-02       Impact factor: 3.395

View more
  14 in total

1.  The role of TRPA1 in muscle pain and mechanical hypersensitivity under inflammatory conditions in rats.

Authors:  J Asgar; Y Zhang; J L Saloman; S Wang; M-K Chung; J Y Ro
Journal:  Neuroscience       Date:  2015-09-21       Impact factor: 3.590

2.  TRPV1 in Pain and Itch.

Authors:  Fengxian Li; Fang Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  P2X receptor channels in chronic pain pathways.

Authors:  Louis-Philippe Bernier; Ariel R Ase; Philippe Séguéla
Journal:  Br J Pharmacol       Date:  2017-08-17       Impact factor: 8.739

4.  Acute intermittent hypoxia with concurrent hypercapnia evokes P2X and TRPV1 receptor-dependent sensory long-term facilitation in naïve carotid bodies.

Authors:  Arijit Roy; Melissa M J Farnham; Fatemeh Derakhshan; Paul M Pilowsky; Richard J A Wilson
Journal:  J Physiol       Date:  2018-01-04       Impact factor: 5.182

5.  Sex differences and mechanisms of muscle pain.

Authors:  Luis F Queme; Michael P Jankowski
Journal:  Curr Opin Physiol       Date:  2019-04-02

6.  The interaction between P2X3 and TRPV1 in the dorsal root ganglia of adult rats with different pathological pains.

Authors:  Jie Yu; Junying Du; Junfan Fang; Yingjun Liu; Xuaner Xiang; Yi Liang; Xiaomei Shao; Jianqiao Fang
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

7.  Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia.

Authors:  Michaela Prochazkova; Anita Terse; Niranjana D Amin; Bradford Hall; Elias Utreras; Harish C Pant; Ashok B Kulkarni
Journal:  Mol Pain       Date:  2013-12-21       Impact factor: 3.395

8.  Sex differences in primary muscle afferent sensitization following ischemia and reperfusion injury.

Authors:  Jessica L Ross; Luis F Queme; Jordan E Lamb; Kathryn J Green; Michael P Jankowski
Journal:  Biol Sex Differ       Date:  2018-01-03       Impact factor: 5.027

9.  Electroacupuncture inhibits the interaction between peripheral TRPV1 and P2X3 in rats with different pathological pain.

Authors:  Yingjun Liu; Junying Du; Junfan Fang; Xuaner Xiang; Yingling Xu; Sisi Wang; Haiju Sun; Jianqiao Fang
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

10.  ATP-sensitive muscle afferents activate spinal trigeminal neurons with meningeal afferent input in rat - pathophysiological implications for tension-type headache.

Authors:  Moritz Nöbel; Stephan Feistel; Jens Ellrich; Karl Messlinger
Journal:  J Headache Pain       Date:  2016-08-26       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.